GoKawiilOrgan-on-a-chip lung model from Harvard's Wyss Institute faces slow scientific adoption
In 2007, Harvard bioengineer Donald Ingber's team built a 'lung-on-a-chip'—a small polymer device lined with human lung cells that mimics breathing motion and reacts to bacteria and inflammatory proteins much like real lung tissue. Science initially rejected their 2010 paper unless they validated the chip against mouse experiments, which they did before publication; the study has since been cited nearly 5,400 times, yet organ-chip technology still struggles to replace animal testing in mainstream research.
GoKawiil's interpretation of the reporting above, not reported fact.
The episode illustrates how deeply animal testing is embedded as the default validation standard in biomedical science, even when alternative technologies show strong predictive results. This suggests that regulatory and scientific inertia—not just technical readiness—may be the main barrier preventing wider adoption of chip-based testing, which could eventually reduce reliance on animal experiments in drug and toxicology research.
- Harvard's Wyss Institute developed an early lung-on-a-chip in 2007 that mimicked breathing motion.
- Science journal required mouse-based validation before publishing the 2010 study, despite the chip's promising results.
- Organ-on-a-chip technology remains scientifically promising but has been slow to displace traditional animal testing methods.
Source: spectrum.ieee.org — Brandon Keim, 2026-09-29
Published there as: “Tech to Replace Animal Testing Is Almost Ready. Scientists Are Not”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.